Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $25.62 in the prior trading day, Nurix Therapeutics Inc (NASDAQ: NRIX) closed at $24.10, down -5.93%. In other words, the price has decreased by -$5.93 from its previous closing price. On the day, 0.63 million shares were traded. NRIX stock price reached its highest trading level at $25.6175 during the session, while it also had its lowest trading level at $23.5.
Ratios:
Our goal is to gain a better understanding of NRIX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.57 and its Current Ratio is at 5.57. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.
On July 31, 2024, Truist started tracking the stock assigning a Buy rating and target price of $36.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 03 ’24 when Ring Christine sold 9,050 shares for $24.94 per share. The transaction valued at 225,736 led to the insider holds 24,592 shares of the business.
CHRISTINE RING bought 9,050 shares of NRIX for $228,060 on Sep 03 ’24. On Aug 26 ’24, another insider, Ring Christine, who serves as the Chief Legal Officer of the company, sold 9,870 shares for $25.01 each. As a result, the insider received 246,843 and left with 24,592 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 1552326784 and an Enterprise Value of 1138006016. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.92 while its Price-to-Book (P/B) ratio in mrq is 4.18. Its current Enterprise Value per Revenue stands at 18.266 whereas that against EBITDA is -6.607.
Stock Price History:
Over the past 52 weeks, NRIX has reached a high of $26.31, while it has fallen to a 52-week low of $4.22. The 50-Day Moving Average of the stock is 5.07%, while the 200-Day Moving Average is calculated to be 54.95%.
Shares Statistics:
The stock has traded on average 773.10K shares per day over the past 3-months and 702800 shares per day over the last 10 days, according to various share statistics. A total of 64.41M shares are outstanding, with a floating share count of 63.34M. Insiders hold about 1.67% of the company’s shares, while institutions hold 101.16% stake in the company. Shares short for NRIX as of 1724976000 were 9261820 with a Short Ratio of 11.98, compared to 1722384000 on 9321186. Therefore, it implies a Short% of Shares Outstanding of 9261820 and a Short% of Float of 15.540000000000001.
